Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours

Ya Qi Cheng; Shou Bi Wang; Jia Hui Liu; Lin Jin; Ying Liu; Chao Yang Li; Ya Ru Su; Yu Run Liu; Xuan Sang; Qi Wan; Chang Liu; Liu Yang; Zhi Chong Wang

doi:10.1111/cpr.12865

Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours

Ya Qi Cheng, Shou Bi Wang, Jia Hui Liu, Lin Jin, Ying Liu, Chao Yang Li, Ya Ru Su, Yu Run Liu, Xuan Sang, Qi Wan, Chang Liu, Liu Yang, Zhi Chong Wang

Research output: Contribution to journal › Review article › peer-review

Abstract

The tumour microenvironment (TME) plays a pivotal role in tumour fate determination. The TME acts together with the genetic material of tumour cells to determine their initiation, metastasis and drug resistance. Stromal cells in the TME promote the growth and metastasis of tumour cells by secreting soluble molecules or exosomes. The abnormal microenvironment reduces immune surveillance and tumour killing. The TME causes low anti-tumour drug penetration and reactivity and high drug resistance. Tumour angiogenesis and microenvironmental hypoxia limit the drug concentration within the TME and enhance the stemness of tumour cells. Therefore, modifying the TME to effectively attack tumour cells could represent a comprehensive and effective anti-tumour strategy. Normal cells, such as stem cells and immune cells, can penetrate and disrupt the abnormal TME. Reconstruction of the TME with healthy cells is an exciting new direction for tumour treatment. We will elaborate on the mechanism of the TME to support tumours and the current cell therapies for targeting tumours and the TME—such as immune cell therapies, haematopoietic stem cell (HSC) transplantation therapies, mesenchymal stem cell (MSC) transfer and embryonic stem cell-based microenvironment therapies—to provide novel ideas for producing breakthroughs in tumour therapy strategies.

Original language	English (US)
Article number	e12865
Journal	Cell Proliferation
Volume	53
Issue number	8
DOIs	https://doi.org/10.1111/cpr.12865
State	Published - Aug 1 2020
Externally published	Yes

Keywords

cell therapy
stem cell microenvironment
tumour microenvironment
tumour targeting

ASJC Scopus subject areas

Cell Biology

Access to Document

10.1111/cpr.12865

Cite this

@article{ee742f4c8f924294a0e84d2aec8fe4dc,

title = "Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours",

abstract = "The tumour microenvironment (TME) plays a pivotal role in tumour fate determination. The TME acts together with the genetic material of tumour cells to determine their initiation, metastasis and drug resistance. Stromal cells in the TME promote the growth and metastasis of tumour cells by secreting soluble molecules or exosomes. The abnormal microenvironment reduces immune surveillance and tumour killing. The TME causes low anti-tumour drug penetration and reactivity and high drug resistance. Tumour angiogenesis and microenvironmental hypoxia limit the drug concentration within the TME and enhance the stemness of tumour cells. Therefore, modifying the TME to effectively attack tumour cells could represent a comprehensive and effective anti-tumour strategy. Normal cells, such as stem cells and immune cells, can penetrate and disrupt the abnormal TME. Reconstruction of the TME with healthy cells is an exciting new direction for tumour treatment. We will elaborate on the mechanism of the TME to support tumours and the current cell therapies for targeting tumours and the TME—such as immune cell therapies, haematopoietic stem cell (HSC) transplantation therapies, mesenchymal stem cell (MSC) transfer and embryonic stem cell-based microenvironment therapies—to provide novel ideas for producing breakthroughs in tumour therapy strategies.",

keywords = "cell therapy, stem cell microenvironment, tumour microenvironment, tumour targeting",

author = "Cheng, {Ya Qi} and Wang, {Shou Bi} and Liu, {Jia Hui} and Lin Jin and Ying Liu and Li, {Chao Yang} and Su, {Ya Ru} and Liu, {Yu Run} and Xuan Sang and Qi Wan and Chang Liu and Liu Yang and Wang, {Zhi Chong}",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Cell Proliferation published by John Wiley & Sons Ltd",

year = "2020",

month = aug,

day = "1",

doi = "10.1111/cpr.12865",

language = "English (US)",

volume = "53",

journal = "Cell Proliferation",

issn = "0960-7722",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

TY - JOUR

T1 - Modifying the tumour microenvironment and reverting tumour cells

T2 - New strategies for treating malignant tumours

AU - Cheng, Ya Qi

AU - Wang, Shou Bi

AU - Liu, Jia Hui

AU - Jin, Lin

AU - Liu, Ying

AU - Li, Chao Yang

AU - Su, Ya Ru

AU - Liu, Yu Run

AU - Sang, Xuan

AU - Wan, Qi

AU - Liu, Chang

AU - Yang, Liu

AU - Wang, Zhi Chong

PY - 2020/8/1

Y1 - 2020/8/1

N2 - The tumour microenvironment (TME) plays a pivotal role in tumour fate determination. The TME acts together with the genetic material of tumour cells to determine their initiation, metastasis and drug resistance. Stromal cells in the TME promote the growth and metastasis of tumour cells by secreting soluble molecules or exosomes. The abnormal microenvironment reduces immune surveillance and tumour killing. The TME causes low anti-tumour drug penetration and reactivity and high drug resistance. Tumour angiogenesis and microenvironmental hypoxia limit the drug concentration within the TME and enhance the stemness of tumour cells. Therefore, modifying the TME to effectively attack tumour cells could represent a comprehensive and effective anti-tumour strategy. Normal cells, such as stem cells and immune cells, can penetrate and disrupt the abnormal TME. Reconstruction of the TME with healthy cells is an exciting new direction for tumour treatment. We will elaborate on the mechanism of the TME to support tumours and the current cell therapies for targeting tumours and the TME—such as immune cell therapies, haematopoietic stem cell (HSC) transplantation therapies, mesenchymal stem cell (MSC) transfer and embryonic stem cell-based microenvironment therapies—to provide novel ideas for producing breakthroughs in tumour therapy strategies.

AB - The tumour microenvironment (TME) plays a pivotal role in tumour fate determination. The TME acts together with the genetic material of tumour cells to determine their initiation, metastasis and drug resistance. Stromal cells in the TME promote the growth and metastasis of tumour cells by secreting soluble molecules or exosomes. The abnormal microenvironment reduces immune surveillance and tumour killing. The TME causes low anti-tumour drug penetration and reactivity and high drug resistance. Tumour angiogenesis and microenvironmental hypoxia limit the drug concentration within the TME and enhance the stemness of tumour cells. Therefore, modifying the TME to effectively attack tumour cells could represent a comprehensive and effective anti-tumour strategy. Normal cells, such as stem cells and immune cells, can penetrate and disrupt the abnormal TME. Reconstruction of the TME with healthy cells is an exciting new direction for tumour treatment. We will elaborate on the mechanism of the TME to support tumours and the current cell therapies for targeting tumours and the TME—such as immune cell therapies, haematopoietic stem cell (HSC) transplantation therapies, mesenchymal stem cell (MSC) transfer and embryonic stem cell-based microenvironment therapies—to provide novel ideas for producing breakthroughs in tumour therapy strategies.

KW - cell therapy

KW - stem cell microenvironment

KW - tumour microenvironment

KW - tumour targeting

UR - http://www.scopus.com/inward/record.url?scp=85087167454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087167454&partnerID=8YFLogxK

U2 - 10.1111/cpr.12865

DO - 10.1111/cpr.12865

M3 - Review article

C2 - 32588948

AN - SCOPUS:85087167454

SN - 0960-7722

VL - 53

JO - Cell Proliferation

JF - Cell Proliferation

IS - 8

M1 - e12865

ER -

Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this